Vitamin D, the sunshine vitamin, has been important not only for the evolution of a healthy calcified vertebrate skeleton but it also evolved into a hormone that has a wide diversity of biologic effects. During exposure to sunlight the ultraviolet B radiation converts 7-dehydrocholesterol to previtamin D3 which in turn rapidly isomerizes to vitamin D3. Once formed, vitamin D3 is metabolized in the liver to 25-hydroxyvitamin D3 and in the kidneys to its active form 1,25- dihydroxyvitamin D3. 1,25-dihydroxyvitamin D3 interacts with its vitamin D receptor in calcium regulating tissues to regulate calcium metabolism and bone health. It is now recognized that most cells in the body have a vitamin D receptor and they also have the capability of producing 1,25-dihydroxyvitamin D3 which in turn is capable of regulating a wide variety of genes that have important functions in regulating cell growth, modulating immune function and cardiovascular health. Epidemiologic evidence and prospective studies have linked vitamin D deficiency with increased risk of many chronic diseases including autoimmune diseases, cardiovascular disease, deadly cancers, type II diabetes and infectious diseases. Vitamin D deficiency and insufficiency have been defined as a 25-hydroxyvitamin D < 20 ng/ml and 21-29 ng/ml respectively. For every 100 IU of vitamin D ingested the blood level of 25-hydroxyvitamin D, the measure vitamin D status, increases by ∼1 ng/ml. It is estimated that children need at least 400-1000 IU of vitamin D a day while teenagers and adults need at least 2000 IU of vitamin D a day to satisfy their bodys vitamin D requirement. It is estimated that 1 billion people worldwide are vitamin D deficient or insufficient. Correcting and preventing this deficiency could have an enormous impact on reducing health costs worldwide.
Vitamin D, sunlight, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, skeleton, cancer, diabetes, vitamin D deficiency, autoimmune disease, ergosterol, DBP, Caucasians, UVB radiation, Provitamin D3, Cholecalciferol, Ergocalciferol, VDR, RANKL, FGF 23, hyperparathyroidism, osteopenia, osteoporosis, osteomalacia, lupus vulgaris, rheumatoid arthritis, inflammatory bowel disease, non-melanoma skin cancer, fat malabsorption syndrome, 25(OH)D
Boston University School of Medicine, 85 East Newton Street, M-1013, MA 02118, Boston, USA.